Herbert Loong

26PUBLICATIONS
187CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Aug 06, 2026
Consensus recommendations for the management of Dato-DXd-associated adverse events in patients with advanced/metastatic NSCLC: insights from a multiregional steering committee.

|Aug 05, 2026
Lung cancer across borders: From molecular epidemiology to precision treatment strategies.

|Jun 01, 2026
Tumor-Agnostic Therapies: Translating Scientific Breakthroughs Into Global Implementation.

|Apr 24, 2026
In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid Tumors.

|Apr 09, 2026
Why are we still using cisplatin? : Rationale for the continued use of cisplatin in oncology.

Jemma Arakelyan, Herbert Loong, Robert Peter Gale

|Jan 15, 2026
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium.

Sarah Waliany, Alissa J Cooper, Stephen V Liu

Pageof 5

Frequent Collaborators

5 joint publications

Vivek Subbiah

4 joint publications

Alexander Drilon

3 joint publications

Koichi Goto

3 joint publications

Chun Sing Lam